Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease

NCT05598489 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT05598489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05598489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
December 7, 2022
Completion date
July 31, 2024
Enrollment
3,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, microbiome, ulcerative colitis